Breaking News
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
October 22, 2018 - Analyzing mouse’s potential as animal model of decision-making
October 22, 2018 - Radiotherapy can prolong survival in prostate cancer
October 22, 2018 - A genetic mutation involved in relapse
October 21, 2018 - Report reveals growing impact of cannabis on young people
October 21, 2018 - NSF awards $5 million grant to help scientists magnify societal impact of research
October 21, 2018 - Fertility Rates Down for Each Urbanization Level 2007 to 2017
October 21, 2018 - Genetically engineered 3-D human muscle transplant in a murine model
October 21, 2018 - Moms’ tight work schedules may affect their children’s sleep
October 21, 2018 - AHA: No Direct Link Between Preeclampsia and Cognitive Impairment, Study Finds
October 21, 2018 - Weight loss success linked with active self-control regions of the brain
October 21, 2018 - Scripps researchers successfully test potential new smoking-cessation treatment in rodents
October 21, 2018 - More accurate and less stressful way to measure a baby’s heartbeat
October 21, 2018 - Researchers show better cardiorespiratory fitness leads to longer life
October 21, 2018 - Healthy candies for diabetic patients
October 21, 2018 - Environment impact of microplastics remains unclear
October 21, 2018 - Antibiotics for appendicitis? Surgery often not needed
October 21, 2018 - AHA and AMA recognize more than 800 medical practices, health systems for blood pressure control
October 21, 2018 - Scientists obtain clearest ever image of Ebola virus protein
October 21, 2018 - Study reveals connection between two proteins known to be hyperactive in cancer
October 21, 2018 - Gabapentin Beats Pregabalin for Chronic Sciatica
October 21, 2018 - Cosmetic surgeons offering incomplete information for breast augmentation customers
October 21, 2018 - Chronic sleep disruption in early adult life accelerates AD-related tau pathology
October 21, 2018 - Take 10 for Mindfulness – Drugs.com MedNews
October 21, 2018 - Length of breathing disruption in OSA may be better predictor of mortality risk
October 21, 2018 - ApoE4 gene linked with chronic inflammation increases risk for Alzheimer’s disease
October 21, 2018 - Mother-daughter conflict associated with suicide risk in abused adolescent girls
October 21, 2018 - Scientists molding bacteria into unnatural shapes
October 21, 2018 - High diet quality associated with lower risk of death in colorectal cancer patients
October 21, 2018 - Discharged mental health patients ‘at greater risk of dying’
October 21, 2018 - Research provides insight into neurobiology of aggression and bullying
October 21, 2018 - As billions in tax dollars flow to private Medicaid plans, Who’s minding the store?
October 21, 2018 - Neuroscientists identify brain region that appears to be related to food preference decisions
October 21, 2018 - Deaths related to air pollution in the U.S. decreased by 47% between 1990 and 2010
October 21, 2018 - Study shows correlation between spatial memory and the sense of smell
October 21, 2018 - Increased cardiorespiratory fitness associated with reduced long-term mortality
October 21, 2018 - IU researchers receive $1.55 million from NIH to improve chronic-disease management
October 21, 2018 - Income and wealth affect the mental health of Australians, study shows
October 21, 2018 - Patients with hypertension and psoriasis more often require cardiovascular interventions
October 20, 2018 - Leading hip-hop videos depict use of tobacco and marijuana products, study finds
October 20, 2018 - Dose Range of IV Ketamine for Adjunct Tx of Depression Tested
October 20, 2018 - Infants can distinguish between leaders and bullies, study finds
October 20, 2018 - Mad Cow disease found on Aberdeenshire farm
October 20, 2018 - Study identifies factors associated with prescription opioid misuse among students
October 20, 2018 - Scientists uncover key regulator of mTORC1 in cancer growth
No Difference in Infant Cognitive Scores for Brain Injury Tx

No Difference in Infant Cognitive Scores for Brain Injury Tx

image_pdfDownload PDFimage_print

Action Points

  • Note that this small trial found similar overall results between VP-shunting and endoscopic treatment in children with post-infectious hydrocephalus.
  • The endoscopic procedure is more definitive, with a lower failure rate over time, but concerns of worse neurologic outcomes have limited its adoption up to this point.

There was no difference in cognitive outcomes when African infants with post-infectious hydrocephalus, an accumulation of cerebrospinal fluid in the brain, were treated with a shunt or a two-part procedure designed to divert the flow of fluid and cauterize certain areas of the brain, a small randomized trial found.

Infants who underwent endoscopic third ventriculostomy with choroid plexus cauterization (ETV-CPC) showed no difference in median cognitive scores at 12 months compared to infants treated with ventriculoperitoneal shunting, reported Abhaya V. Kulkarni, MD, of the University of Toronto Hospital for Sick Children, and colleagues.

There was also no difference in language or motor skills or in brain volume between the two procedures as performed in Uganda, the authors wrote in the New England Journal of Medicine.

They said that there is “uncertainty” regarding the benefits of the two procedures for infants with this condition. While shunting is technically straightforward, with a lower rate of failure in the months after surgery, the authors said, it has a higher long-term failure rate that often requires urgent surgery. In addition, “shunt failure can be fatal in regions of the world where there is no access to immediate neurological care,” they wrote.

But shunting is also thought to reduce the ventricle size more than ETV-CPC, which could lead to a better cognitive outcome for the patient, though the authors added that “this difference between procedures has been shown inconsistently.”

“Others have suggested that shunts are a better treatment in regard to neurologic development or brain growth, but we found this was not the case,” co-author Benjamin Warf, MD, of Boston Children’s Hospital said in a statement. “There are many advantages to avoiding lifelong dependence on a shunt.”

Researchers randomized 100 Ugandan infants with post-infectious hydrocephalus, who were less than 180 days of age, with a mother who was over 18, and lived in an area where they could complete follow-up. They were evaluated via the cognitive scaled score on the Bayley Scales of Infant Development, Third Edition, 12 months following surgery.

Overall, 42 infants underwent endoscopic ventriculostomy and 48 underwent placement of a ventriculoperitoneal-shunt. Infants were a mean age of about 3 months, and there were around 40% girls in both groups. Head circumference and cerebrospinal fluid volume was greater in the shunt group, the author said, but noted no other significant between-group differences at baseline.

There was no significant difference in median cognitive scores between the two groups at 12 months (4 in ETV-CPC group versus 2 in shunt group, 95% CI -2 to 0, P=0.35). Kulkarni and colleagues also found no significant difference in expressive language score, receptive language score, general motor score or fine motor score.

While there was no difference in brain volume at 12 months between groups, median cerebrospinal fluid volume was significantly lower in the shunt group than in the ETV-CPC group.

There were 18 treatment failures in the ETV-CPC group compared to 12 in the shunt group, but the difference was non-significant. In a statement, Warf characterized that finding as surprising.

“ETV/CPC is expected to have a higher short term failure rate, whereas shunts tend to fail more over time,” Warf said. “We expect that there will be no further ETV/CPC failures, which nearly all occur within 6 months, but that the shunts will continue to fail as we follow this cohort.”

There were nine deaths, two of which were treatment-related. One patient in the ETV-CPC group had treatment failure 8 months after surgery, the authors said, and one patient started in the ETV-CPC group, crossed over to shunting and developed ventriculitis (inflammation of the ventricles) and subdural empyema (a collection of pus in certain brain matter).

But they noted that “the overall developmental outcome was relatively poor for both treatments,” with nearly all patients starting with abnormally low brain volume at baseline, and only a quarter having normal brain volume by year 1, they said.

Limitations to the data include that it only addressed postinfectious hydrocephalus, that the single center nature of the trial limits generalizability, and a relatively short follow-up period of 1 year.

“We will continue to follow these children, but the results further raise our level of confidence in recommending ETV/CPC as the initial treatment for most infants with hydrocephalus,” Warf said.

This study was supported by the NIH, the National Institute of Child and Human Development, and the Fogarty International Center.

Kulkarni disclosed no conflicts of interest.

One co-author disclosed support from General Electric Global Research.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2017-12-20T17:00:00-0500

Tagged with:

About author

Related Articles